FDA regulators grant AliveCor new clearance for an at-home heart rhythm test for diagnosing asymptomatic atrial fibrillation.
AliveCor hit a major turning point for its smartphone-based ECG technology with FDA clearance for a new algorithm that helps patients diagnose their own heart rhythms.
News Well, Regulatory/Clearance, 510(k), Cardiac Rhythm Management, Diagnostics, Digital Health, Food & Drug Administration (FDA), mHealth (Mobile Health)
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1z7bqAO
Cap comentari:
Publica un comentari a l'entrada